393 related articles for article (PubMed ID: 28279034)
1. [Clinical significance of cytogenetic monitoring in chronic myeloid leukemia].
Pan CY; Xu N; He BL; Cao R; Liao LB; Yin CX; Lan YQ; Lu ZY; Huang JX; Sun J; Feng R; Liu QF; Liu XL
Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):112-117. PubMed ID: 28279034
[No Abstract] [Full Text] [Related]
2. [Analysis of the Relationship between Cytogenetic Changes and Course Evolution of Patients with CML during TKI Treatment].
Wang K; Liu T; Dai J; Pang YX; Wang Q
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):136-140. PubMed ID: 32027266
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of clinical features and prognosis of patients with chronic myelogenous leukemia harboring additional chromosomal abnormalities in Ph-positive cells].
Dong XY; Li YL; Wu CY; Shang BJ; Zhang L; Cheng W; Zhu ZM
Zhonghua Xue Ye Xue Za Zhi; 2021 Aug; 42(8):660-665. PubMed ID: 34547872
[No Abstract] [Full Text] [Related]
4. Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.
Fabarius A; Kalmanti L; Dietz CT; Lauseker M; Rinaldetti S; Haferlach C; Göhring G; Schlegelberger B; Jotterand M; Hanfstein B; Seifarth W; Hänel M; Köhne CH; Lindemann HW; Berdel WE; Staib P; Müller MC; Proetel U; Balleisen L; Goebeler ME; Dengler J; Falge C; Kanz L; Burchert A; Kneba M; Stegelmann F; Pfreundschuh M; Waller CF; Spiekermann K; Brümmendorf TH; Edinger M; Hofmann WK; Pfirrmann M; Hasford J; Krause S; Hochhaus A; Saußele S; Hehlmann R;
Ann Hematol; 2015 Dec; 94(12):2015-24. PubMed ID: 26385387
[TBL] [Abstract][Full Text] [Related]
5. Overview of clinical and genetic features of CML patients with variant Philadelphia translocations involving chromosome 7: A case series.
Bayrak AG; Daglar Aday A; Yavuz AS; Nalcaci M; Ozbalak MM; Cefle K; Ozturk S; Palanduz S
Leuk Res; 2021 Dec; 111():106725. PubMed ID: 34634595
[TBL] [Abstract][Full Text] [Related]
6. The impact of additional cytogenetic abnormalities at diagnosis and during therapy with tyrosine kinase inhibitors in Chronic Myeloid Leukaemia.
Crisan AM; Coriu D; Arion C; Colita A; Jardan C
J Med Life; 2015; 8(4):502-8. PubMed ID: 26664479
[TBL] [Abstract][Full Text] [Related]
7. Molecular cytogenetic characterization of Philadelphia-negative rearrangements in chronic myeloid leukemia patients.
Bennour A; Bellâaj H; Ben Youssef Y; Elloumi M; Khelif A; Saad A; Sennana H
J Cancer Res Clin Oncol; 2011 Sep; 137(9):1329-36. PubMed ID: 21739181
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.
Johansson B; Fioretos T; Mitelman F
Acta Haematol; 2002; 107(2):76-94. PubMed ID: 11919388
[TBL] [Abstract][Full Text] [Related]
9. [Evolvement of a five-way translocation t(5;9;22;6;17) from a four-way Philadelphia translocation t(5;9;22;6) in a rare case of chronic myeloid leukemia].
Kong S; Gu Y; Qin Y; Wang Z; Feng L; Jiang Q; Lai Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Dec; 37(12):1395-1398. PubMed ID: 33306831
[TBL] [Abstract][Full Text] [Related]
10. Chronic myeloid leukemia with variation of translocation at (Ph) [ins (22;9) (q11;q21q34)]: a case report.
Wang Z; Zen W; Meng F; Xin X; Luo L; Sun H; Zhou J; Huang L
Int J Clin Exp Pathol; 2015; 8(10):13707-10. PubMed ID: 26722598
[TBL] [Abstract][Full Text] [Related]
11. Chronic myeloid leukemia with complex karyotypes: Prognosis and therapeutic approaches.
Asnafi AA; Deris Zayeri Z; Shahrabi S; Zibara K; Vosughi T
J Cell Physiol; 2019 May; 234(5):5798-5806. PubMed ID: 30430567
[TBL] [Abstract][Full Text] [Related]
12. Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy.
Luatti S; Baldazzi C; Marzocchi G; Ameli G; Bochicchio MT; Soverini S; Castagnetti F; Tiribelli M; Gugliotta G; Martinelli G; Baccarani M; Cavo M; Rosti G; Testoni N
Oncotarget; 2017 May; 8(18):29906-29913. PubMed ID: 28404889
[TBL] [Abstract][Full Text] [Related]
13. Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients.
Meggyesi N; Kozma A; Halm G; Nahajevszky S; Bátai A; Fekete S; Barta A; Ujj G; Lueff S; Sipos A; Adám E; Bors A; Reményi P; Masszi T; Tordai A; Andrikovics H
Acta Haematol; 2012; 127(1):34-42. PubMed ID: 22005133
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence in situ hybridization: a highly efficient technique of molecular diagnosis and predication for disease course in patients with myeloid leukemias.
Amare PS; Baisane C; Saikia T; Nair R; Gawade H; Advani S
Cancer Genet Cytogenet; 2001 Dec; 131(2):125-34. PubMed ID: 11750052
[TBL] [Abstract][Full Text] [Related]
15. Philadelphia chromosome-negative chronic myelogenous leukemia without breakpoint cluster region rearrangement: a chronic myeloid leukemia with a distinct clinical course.
Kurzrock R; Kantarjian HM; Shtalrid M; Gutterman JU; Talpaz M
Blood; 1990 Jan; 75(2):445-52. PubMed ID: 2403827
[TBL] [Abstract][Full Text] [Related]
16. [Progress in laboratory medicine in chronic myeloid leukemia].
Miura A
Rinsho Byori; 1998 Dec; 46(12):1226-31. PubMed ID: 9916508
[TBL] [Abstract][Full Text] [Related]
17. Leukemia cell lines: in vitro models for the study of Philadelphia chromosome-positive leukemia.
Drexler HG; MacLeod RA; Uphoff CC
Leuk Res; 1999 Mar; 23(3):207-15. PubMed ID: 10071072
[TBL] [Abstract][Full Text] [Related]
18. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
[TBL] [Abstract][Full Text] [Related]
19. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML.
van der Plas DC; Grosveld G; Hagemeijer A
Cancer Genet Cytogenet; 1991 Apr; 52(2):143-56. PubMed ID: 2021916
[TBL] [Abstract][Full Text] [Related]
20. The first case of six-way complex translocation of t(4;7;9;22;8;14) in a patient with chronic myeloid leukemia.
Bi X; Li C; Shang M; Han B; Li H; Sun L; Lin Y; Yang S
J Hematop; 2024 Jun; 17(2):97-101. PubMed ID: 38492169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
